Sort by
Refine Your Search
-
Employer
-
Field
-
algebraic graph theory, group theory, or a related discipline, with expertise in graph symmetry, group actions on combinatorial structures, or related areas, preferably with the following skills: Have a
-
algebraic graph theory, group theory, or a related discipline, with expertise in graph symmetry, group actions on combinatorial structures, or related areas, preferably with the following skills: Have a
-
, flexible working arrangements may be negotiated. As the successful candidate you will play a pivotal role in designing and optimizing novel small molecules and drug candidates for a GPCR drug discovery
-
to the developing and optimizing protein crystallization workflows and advancing electron crystallography methods for protein structure determination. The successful candidate will work closely with the group leader
-
on an ARC-funded, laboratory-based project, “Rest and Readiness: What is the Optimal Nap Length During Night Shifts?”, you will drive innovative research at CQUniversity’s Appleton Institute in
-
bioassay guided approach to prioritize microbial extracts that exhibit the desired antibiotic properties, followed by cultivation and chemical profiling to optimize production and dereplicate, ahead
-
. Collaborates on the assembly, alignment, and optimization of the systems. Conduct testing and operation of the systems to ensure functionality and performance. Generate high-quality research outputs by
-
contributing to the development of next-generation water management technologies. The role will initially focus on real-time control modelling and performance optimization of wetland systems, with potential
-
/bio-integrated devices, with establishment of Bluetooth communication, PCB design and assembly optimize data acquisition, storage, transfer and processing attend conferences and seminars in the field
-
population modelling approaches. You will collaborate with an interdisciplinary team of mRNA scientists, pharmacometricians, clinical pharmacologists, and drug developers to optimize therapeutic strategies